Aposense

Aposense is an Israeli biotechnology company specializing in the development of a universal platform called Molecular Nano Motors (MNMs) for the delivery of genetic drugs, such as siRNA, into cells. The company leverages a novel mechanism of action that utilizes membrane electrical forces, specifically the Membrane Dipole Potential, to achieve this. Aposense operates in the genetic therapeutics market, serving pharmaceutical companies and research institutions focused on genetic medicine. The business model revolves around licensing its technology to these clients, thereby generating revenue through licensing fees and potential royalties from successful drug applications. The company is led by Professor Roger D. Kornberg, a Nobel Prize Laureate, and boasts full-capacity research facilities to support its innovative endeavors.

Keywords: gene delivery, biotechnology, siRNA, membrane electrical fields, genetic therapeutics, Molecular Nano Motors, licensing, pharmaceutical, research institutions, Israel.